Circular RNA Expression Signatures Provide Promising Diagnostic and Therapeutic Biomarkers for Chronic Lymphocytic...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Chronic lymphocytic leukemia (CLL) presents a growing incidence and significant relapse rates post-treatment.
• The need for reliable diagnostic biomarkers in CLL management is critical.
• Circular RNAs (circRNAs) are emerging as significant players in various biological processes and diseases.

Purpose of the Study:

• To identify and validate a panel of circRNAs for the early diagnosis of CLL.
• To assess the diagnostic performance of circRNA biomarkers compared to existing clinical scales.
• To explore the prognostic value and therapeutic potential of identified circRNAs in CLL.

Main Methods:

• Bioinformatic analysis identified deregulated circRNAs in CLL cell models.
• Retrieved circRNAs were applied to online patient datasets (training cohort, n=100).
• Diagnostic performance was analyzed across CLL Binet stages and validated in independent cohorts (n=220, n=251).

Main Results:

• A circRNA-based panel demonstrated superior diagnostic performance compared to current clinical risk scales.
• The identified circRNA biomarkers showed significant predictive value for early CLL detection.
• Analysis revealed associations between circRNAs, cancer-related signaling pathways, and potential therapeutic compounds.

Conclusions:

• CircRNA biomarkers offer a promising avenue for the early detection and personalized treatment of CLL.
• The developed circRNA panel enhances diagnostic accuracy and prognostic assessment in CLL patients.
• This study provides a foundation for novel therapeutic strategies targeting circRNAs in CLL management.